Kansas banned kratom in April 2026. Louisiana banned it months earlier. Iowa is considering making it a Schedule I drug—the same legal category as heroin. But Rhode Island reversed its own ban just last year. Across the United States, kratom—a plant from Southeast Asia that people use as a powder or drink—is facing wildly different treatment depending on where you live.

The federal government hasn't taken a firm stance on kratom yet. The FDA hasn't made it illegal, though it has raised concerns about addiction and contamination. That lack of a national decision has left individual states to figure it out on their own, and they're going in every direction at once.

What Is Kratom, and Why Does It Matter?

Kratom is a plant leaf that comes from Indonesia and other parts of Southeast Asia. People grind it into powder and drink it mixed with water or juice. Some use it to ease chronic pain. Others say it helps them quit opioid painkillers—a drug problem that has devastated American communities.

The leaf contains chemical compounds called alkaloids. One of these, called 7-hydroxymitragynine (7-OH), is particularly potent. Medical experts worry that kratom can become habit-forming, similar to opioids. The American Psychiatric Association stated in 2025 that kratom contains opioid-like compounds and carries a real risk of addiction.

But here's the tension: some people genuinely report that kratom helps them manage severe withdrawal symptoms when quitting heroin or prescription painkillers. The National Institute on Drug Abuse recognizes that people use it for this purpose. There just isn't enough scientific evidence yet to say whether it actually works or how safe it is.

The Patchwork of State Laws

Without a clear federal rule, states are writing their own. Some ban it outright. Some treat it as a food that must follow safety and labeling rules. Some have negotiated deals with sellers to pull it off shelves.

Louisiana banned kratom entirely as of August 1, 2025. Kansas followed with a law in April 2026. Iowa's legislature passed a bill to classify it as a Schedule I controlled substance—meaning possession could result in criminal charges—though as of early 2026 it still needed a vote in the state senate and the governor's signature.

Not all states went the ban route. Ohio didn't ban kratom. Instead, its pharmacy board issued rules requiring anyone who sells kratom to follow the state's food and drug safety laws—which means clear labeling and proof that the product isn't contaminated or unsafe.

California took an active approach: regulators there reported in March 2026 that they had achieved 95% compliance with rules against illegal kratom products. That means state officials are actively checking the market, not just relying on a law sitting on the books.

Missouri's Attorney General achieved a similar result without formally banning kratom. In June 2026, the state secured an agreement with American Shaman, a major retailer, to stop selling kratom products in Missouri altogether. The state used consumer-protection laws rather than criminal drug laws to force the withdrawal—a creative workaround that achieves a ban-like effect without the legislative process.

Rhode Island stands alone. It had banned kratom but reversed that ban in July 2025 after users complained and urged the state to reconsider. This is the one major instance of a state stepping back from a ban.

Why the Specificity on 7-OH Matters

Some states did something strategically interesting: they specifically named 7-OH, the most potent alkaloid, in their bans. California, Missouri, and Iowa all called out 7-OH by name alongside the general kratom plant.

This matters because 7-OH is dozens of times more powerful at opioid receptors than other compounds in kratom leaf. When you ban just "kratom" without naming specific alkaloids, companies can reformulate their products to get around the rule. By explicitly naming 7-OH, states are trying to close that loophole.

What This Means for Shoppers and Retailers

If you sell kratom or health products, you're now playing chess across fifty different boards. A product that's perfectly legal and labeled properly in Ohio might be a controlled substance in Kansas or illegal in California if the label is wrong. Large retailers like American Shaman have to either pull products from certain states or face pressure from attorneys general.

For consumers, it means that what you can legally buy depends on your zip code. It also means you can't count on consistent product quality or safety standards from state to state.

The underlying reason for all this confusion is that the federal government hasn't made a decision. Without a clear national rule from the FDA or the Drug Enforcement Administration, states are left to make their own judgment calls. They're weighing health warnings from federal agencies against real stories from people who say kratom genuinely helps them. And they're dealing with pressure from the kratom industry, which has its own financial interest in keeping the product legal and available.

For now, the pressure seems to lean toward tighter restrictions. Iowa is moving toward a Schedule I classification. Missouri pursued an enforcement action. California is actively policing the market. Rhode Island's reversal was an exception, not a sign of a broader trend. Until the federal government acts, expect more states to make their own rules—and expect those rules to keep varying from state to state.